Company: GHRS
Filing Date: 2025-07-29
Form Type: 20-F/A
Source: 0001140361-25-027850
Chunk: 274

Company: GH Research PLC
Filing Date: 2025-07-29
Form: 20-F/A
Chunk 274
---
 Table of Contents Property, plant and equipment

Property, plant and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the respective assets, which are as follows:

|                   | Estimated Useful 
 Life             |
| IT equipment      | 3years           |
| Office equipment  | 3years           |
| Medical equipment | 2years           |

Leases and right-of-use assets The Group recognizes a right-of-use (“ROU”) asset and a corresponding lease liability for all arrangements in which it is a lessee, except for leases with a term of 12 months or less (short-term leases) and low-value leases. Under IFRS 16, the Group recognizes a ROU asset and a lease liability at the lease commencement date at the present value of the future lease payments, discounted at the Group’s incremental borrowing rate. The ROU asset is subsequently depreciated using the straight-line method over the lease term within depreciation expenses and an interest expense on lease liabilities is recognized within finance expense in the Group’s consolidated statement of comprehensive loss. The interest expense is calculated based on the incremental borrowing rate of the Group. For short-term or low value leases, the Group recognizes the lease payments as an operating expense on a straight-line basis over the term of the lease. Trade payables and other current liabilities Trade payables and other current liabilities are recognized initially at fair value and subsequently measured at amortized cost. Share-based compensation expense The fair value of options granted under the share option plan is recognized as a share-based compensation expense with a corresponding increase in equity. The total expense is recognized over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied. Share capital and additional paid-in capital Share capital Share capital represents the nominal value of outstanding shares (see note 15, “Share capital and reserves”). Additional paid-in capital Amounts of contribution in excess of nominal value are accounted for as additional paid-in capital. Incremental costs directly attributable to equity transactions such as the issue of new capital shares are shown in equity as a deduction, net of tax, from the proceeds within additional paid-in capital. Transaction costs that relate to equity and non-equity transactions are allocated to those transactions using a basis of allocation that is rational and consistent with similar transactions. If the equity instruments are not subsequently issued, the transaction costs would be expensed. Research and development expenses Research and development expenses consist of costs incurred in performing research and development activities, including salaries, share-based